fashion -WSS

fashion

author：knowledge 2025-09-29 18:18:34 - browse：172

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

WSS

The system is set up to fail children with medical complexity

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Coercive sterilizations revealed by STAT prompt outrage

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Teladoc has a new CEO, but challenges remain the same

focus

fashion

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Class action alleges UnitedHealth concealed DOJ probe

Sports medicine is finally prioritizing gender equality

My daughter's legacy lives on through her writing, phage therapy

Supreme Court strikes down use of affirmative action

Study: Why relieving medical debt did not improve financial outcomes

Cancer drug shortages should be causing more outrage

Cheap, fast test for Zika and dengue could cost just $1

Peter Hotez and the public health issue of online harassment

STAT Virtual Event: ASCO Recap, Live!

focus

Coercive sterilizations revealed by STAT prompt outrage

Health care court cases: Humana, Sutter, Novant

Can gargling with Listerine treat gonorrhea of the mouth?

AltruBio raises $225 million to develop ulcerative colitis drug

Brain MRIs reveal impact of 'toxic stress' on Black children

Curing rare childhood diseases will falter unless Congress steps up

explore

focus

leisure time

hotspot